← All trials
NCT06603857
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 27, 2024
- Primary completion
- Dec 31, 2024
- Completion date
- Feb 28, 2025
- First posted
- Sep 19, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 40
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Goldman, Butterwick, Fitzpatrick and GroffLead sponsor
- L'OrealCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.